This evaluation uses advanced lipid biomarkers—ApoB, Lp(a), and hs-CRP—to identify genetic risk, inflammation, and particle-level cholesterol patterns. It offers a different view of cardiovascular risk than a routine cholesterol panel alone.
You’ll complete a focused blood panel measuring ApoB, Lp(a), and hs-CRP. These tests reveal inherited cholesterol disorders, inflammation, and particle-based risk. Dr. Saha interprets each marker personally and explains how they influence your long-term heart health.
Advanced lipid testing can detect markers such as elevated ApoB or high Lp(a) that standard cholesterol panels may not include. This detail can help Dr. Saha discuss treatment options tailored to your results.
Advanced Lipid Testing (ApoB, Lp(a), hs-CRP)
Testing ApoB, Lp(a), and inflammation markers to uncover early cholesterol-related and genetic risk that standard lipid panels miss.
This testing may be appropriate for some patients with high cholesterol, elevated ApoB, high Lp(a), a family history of early heart disease, or unexplained abnormal lipid results. It is not for everyone. Book a visit with Dr. Saha to see if it is right for you.
You’ll complete a simple blood draw that measures ApoB, Lp(a), and hs-CRP. The test is quick and minimally invasive. Dr. Saha reviews your results directly and provides a clear plan to address any elevated levels or genetic markers.
ApoB and Lp(a) are markers used in cardiovascular risk assessment. When levels are elevated, Dr. Saha can discuss treatment options that may include addressing inflammation, cholesterol particle burden, and other risk factors based on your full picture.
This evaluation involves a standard blood draw. Let us know if you tend to feel faint during labs. You may be asked to fast for accurate results.
Once your results are reviewed, Dr. Saha will explain any elevated ApoB, Lp(a), or hs-CRP levels and outline what they mean for your long-term risk. You’ll receive a personalized prevention plan with clear next steps to optimize your cardiovascular health.